Inventor · disambiguated record
Michal Lotem
Also filed as: LOTEM MICHAL
5 granted patents·5 pending applications·4 citations·filing 2006–2024
68Inventor score
Files withHADASIT MED RES SERVICE6GAVISH GALILEE BIO APPL LTD1HADASIT MEDICAL RES SERVICES & DEVELOPMENT LTD1PLURI BIOTECH LTD1YISSUM RES DEV CO1
Top patents by PatentIndex Score
10 records- 0179US10064927B2Allogeneic tumor cell vaccinationHADASIT MED RES SERVICE·Filed 2016·Granted Sep 4, 2018·3 cites·13 claims
- 0279US2025288667A1Genetically engineered mucosal-associated invariant t (mait) cells for adoptive transfer celltherapyPLURI BIOTECH LTD·Filed 2024·Application pending·0 cites
- 0371US9301998B2Allogeneic tumor cell vaccinationHADASIT MED RES SERVICE·Filed 2013·Granted Apr 5, 2016·1 cites·24 claims
- 0465US2023078665A1Cell compositions and methods for cancer therapyHADASIT MED RES SERVICE·Filed 2022·Application pending·0 cites
- 0560US11530251B2Methods for cancer therapy using isolated NTB-A ectodomain polypeptidesHADASIT MED RES SERVICE·Filed 2019·Granted Dec 20, 2022·0 cites·7 claims
- 0648US11834487B2Modulation of SLAMF6 splice variants for cancer therapyHADASIT MEDICAL RES SERVICES & DEVELOPMENT LTD·Filed 2019·Granted Dec 5, 2023·0 cites·25 claims
- 0743US10344073B2Cell compositions and methods for cancer therapyHADASIT MED RES SERVICE·Filed 2015·Granted Jul 9, 2019·0 cites·9 claims
- 0837US2008213237A1Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation ThereofHADASIT MED RES SERVICE·Filed 2006·Application pending·0 cites
- 0937US2006246095A1Multiepitope polypeptides for cancer immunotherapyGAVISH GALILEE BIO APPL LTD·Filed 2006·Application pending·0 cites
- 1026US2017261507A1Methods for Predicting and Monitoring Cancer Patients' Response to Teatment by Measuring Myeloid Derived Suppressor Cells (MDSCs)YISSUM RES DEV CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michal Lotem files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →